Microbiology
Prions
Infectious misfolded protein — PrPc to PrPsc, amyloid, and template-directed conversion with no genome
A prion is an infectious protein — a misfolded copy of a normal brain protein (PrPc) that converts its healthy neighbors into the same misfolded shape (PrPsc), propagating disease with no DNA or RNA at all. The two forms share one identical amino-acid sequence encoded by the PRNP gene; they differ only in fold, with PrPsc jumping from alpha-helix to a beta-sheet-rich conformation that aggregates into amyloid fibrils and resists protease digestion. Prions cause fatal spongiform encephalopathies — Creutzfeldt-Jakob disease, bovine spongiform encephalopathy (mad cow), scrapie, and kuru — and Stanley Prusiner named the particle and formalized the protein-only hypothesis in 1982, winning the 1997 Nobel Prize in Physiology or Medicine.
- Genetic materialNone — protein only
- GenePRNP, chromosome 20
- ConversionPrPc → PrPsc (α-helix → β-sheet)
- Protease-resistant corePrP27-30 (~27–30 kDa)
- Named byPrusiner 1982 · Nobel 1997
- Sterilization134 °C / 1 M NaOH
Interactive visualization
Press play, or step through manually. The visualization is yours to drive — try it before reading on.
Watch the 60-second explainer
A condensed visual walkthrough — narrated, captioned, under a minute.
Why prions matter
- They broke the central dogma of biology. Every other infectious agent — virus, bacterium, fungus, parasite — carries a nucleic-acid genome that copies itself. A prion carries none. Its heritable information is stored in protein shape, and it replicates by forcing a healthy protein to refold. That prions can transmit a specific, heritable trait without DNA or RNA was so heretical that Prusiner's 1982 proposal was met with open hostility for over a decade.
- Mad cow disease reshaped public health. The UK BSE epidemic peaked in 1992 to 1993 with over 37,000 confirmed cattle cases in a single year, driven by feeding cattle meat-and-bone meal from infected animals. When BSE crossed the species barrier into humans as variant CJD (first reported in 1996), it triggered mass cattle culls, feed bans, and permanent changes to blood-donation and beef-import rules worldwide.
- They are effectively indestructible. Prions survive autoclaving at 121 °C, formaldehyde, UV, and ionizing radiation — treatments that annihilate viruses and bacteria by destroying their genomes. There is no genome to destroy, and the amyloid core is thermodynamically extraordinary. This makes contaminated surgical instruments a real transmission route and forces hospitals to quarantine or incinerate suspect tools.
- There is no cure and no vaccine. Every human prion disease is uniformly fatal, usually within months to a couple of years of symptom onset. There is no treatment that halts progression — a stark reminder that a single misfolded protein, given a self-propagating mechanism, can be as lethal as any pathogen.
- They unified the study of neurodegeneration. The prion mechanism — a misfolded protein seeding conversion of its normal counterpart and spreading through the brain — turned out to describe amyloid-beta, tau, and alpha-synuclein too. Alzheimer's, Parkinson's, and ALS are now studied as "prion-like" diseases, making prion biology the template for understanding the most common dementias on Earth.
- They drove a case of recent human evolution. The kuru epidemic imposed such strong selection that the Fore population evolved protective variants in PRNP — a documented example of natural selection acting on humans within living memory.
How prions work, step by step
The cornerstone is that PrPc and PrPsc are the same protein. Both are the product of the PRNP gene on human chromosome 20 — a GPI-anchored cell-surface glycoprotein of roughly 209 mature residues, expressed most heavily on neurons. Their amino-acid sequence is identical, their glycosylation sites are identical, and their GPI anchor is identical. What differs is the fold. PrPc is dominated by alpha-helices (about 42% helix, near-zero beta-sheet) and is monomeric, soluble, and fully digested by the enzyme proteinase K. PrPsc collapses much of that helical content into beta-sheet (roughly 43% beta-sheet), which lets the molecules stack edge-to-edge into insoluble amyloid.
Step one — the seed arrives. A single PrPsc molecule, whether acquired from outside (infection), arising by rare spontaneous misfolding (sporadic disease), or made more likely by a mutation in PRNP (genetic disease), encounters normal PrPc on a cell surface. Step two — templated conversion. PrPsc binds PrPc and acts as a conformational template, lowering the energy barrier for PrPc to refold into the beta-sheet-rich shape. The healthy molecule is not chemically altered; it is physically coerced into a new fold. Step three — the fibril grows. The two identical PrPsc molecules now recruit and convert more PrPc, extending an amyloid fibril one molecule at a time. Step four — fragmentation multiplies the seeds. Growing fibrils break into pieces, and each new end is a fresh conversion surface. This nucleated-polymerization-plus-fragmentation cycle is what makes the process exponential rather than merely additive — one seed becomes two, two become four.
Step five — accumulation and neurotoxicity. Protease-resistant PrPsc aggregates cannot be cleared by the cell's normal protein-quality-control machinery, so they pile up. Neurons develop the microscopic vacuoles that give the brain its "spongiform" (sponge-like) appearance under the microscope, synapses are lost, and neurons die — typically with little or no inflammatory response, because the immune system reads the aggregate as ordinary self-protein. On a diagnostic Western blot, proteinase K trims only the flexible N-terminus of PrPsc, leaving a signature protease-resistant core of about 27 to 30 kilodaltons called PrP27-30 — the classic biochemical fingerprint of a prion.
Prions also come in strains — distinct, heritable disease phenotypes (different incubation times, brain lesion patterns, and glycoform ratios) all encoded in the same PrP sequence. The information distinguishing one strain from another is carried entirely in the precise three-dimensional conformation of the misfolded protein, the closest thing prions have to a "genome." Strain differences also govern the species barrier: how efficiently prions from one species can convert the PrPc of another, which is why BSE could jump to humans while scrapie apparently has not.
Common misconceptions
- "Prions are a kind of virus." No. A virus has a nucleic-acid genome (DNA or RNA) packaged in protein. A prion is only protein, with no genome at all. The two are fundamentally different classes of agent; treating prions as slow viruses — the mainstream view before Prusiner — is exactly the error the field had to overcome.
- "PrPsc has a different amino-acid sequence than PrPc." They are the identical polypeptide. No mutation, no chemical modification, no covalent difference separates them. The entire distinction is conformational — how the same chain of amino acids is folded in three dimensions.
- "The normal prion protein is a disease molecule." PrPc is a normal, functional cell-surface protein present in healthy brains from before birth. Its physiological roles are still debated (copper binding, myelin maintenance, neuroprotection, synaptic signaling), but knockout mice lacking PrPc are viable — and, tellingly, are completely resistant to prion infection because there is no substrate to convert.
- "You can sterilize prions like any other pathogen." Standard autoclaving, alcohol, formaldehyde, and UV all fail. Prions require extreme measures — 134 °C autoclaving for at least 18 minutes, 1 to 2 M sodium hydroxide, or concentrated bleach. Underestimating this has caused iatrogenic (medically transmitted) CJD via instruments, dura mater grafts, and cadaver-derived growth hormone.
- "Prion diseases are always caught from outside." Only a minority of human cases are acquired by infection. Roughly 85% of Creutzfeldt-Jakob disease is sporadic — arising from spontaneous misfolding with no external source — about 10 to 15% is genetic, caused by inherited PRNP mutations, and only a small fraction is acquired (iatrogenic or variant CJD).
- "Alzheimer's and Parkinson's are contagious prion diseases." They use the same seeded-misfolding mechanism and are called "prion-like," but there is no evidence they spread naturally between people. Amyloid-beta, tau, and alpha-synuclein template their own conversion inside a brain, but they are not transmissible by eating tissue the way scrapie or BSE are.
Prion vs virus vs viroid vs amyloid
| Feature | Prion | Virus | Viroid | Non-infectious amyloid |
|---|---|---|---|---|
| Genetic material | None (protein only) | DNA or RNA | Naked circular RNA | None |
| What replicates | Protein conformation | Nucleic-acid genome | RNA genome | Does not self-replicate between hosts |
| Mechanism | Templated misfolding of PrPc | Genome copying + capsid assembly | Host RNA-pol templating | Aggregation of a misfolded protein |
| Destroyed by | 134 °C / 1 M NaOH only | Heat, bleach, UV, formaldehyde | RNases, heat | n/a (endogenous) |
| Immune response | Little to none (self) | Strong (adaptive + innate) | Plant hosts; limited | Variable, often inflammatory |
| Example disease | CJD, BSE, scrapie, kuru | Influenza, HIV, measles | Potato spindle tuber | Type II diabetes (IAPP), Alzheimer's Aβ |
| Nobel recognition | Prusiner 1997 | Multiple | — | — |
Prion diseases at a glance
| Disease | Host | Origin | Notable feature |
|---|---|---|---|
| Sporadic CJD | Humans | Spontaneous misfolding | ~85% of human cases; ~1–2 per million/year |
| Familial CJD / GSS / FFI | Humans | Inherited PRNP mutation | Fatal familial insomnia destroys the thalamus |
| Variant CJD (vCJD) | Humans | Acquired from BSE beef | >200 cases, mostly UK; younger onset |
| Kuru | Humans (Fore people) | Ritual transumption | Vanished after cannibalism ceased |
| Scrapie | Sheep, goats | Naturally transmitted | Known since the 1700s; the founding TSE |
| BSE (mad cow) | Cattle | Contaminated feed | UK epidemic; jumped to humans as vCJD |
| Chronic wasting disease | Deer, elk, moose | Environmentally transmitted | Spreading across North America; highly contagious |
Famous experiments and history
- Scrapie's radiation resistance (Alper & colleagues, 1966–1967). Tikvah Alper and co-workers found that the scrapie agent survived doses of ionizing and ultraviolet radiation that would obliterate any conventional virus, and that its inactivation target was far too small to be a nucleic acid. This was the first hard evidence that the infectious agent might contain no genome — a result so strange that mathematician J. S. Griffith proposed a protein-only "self-replicating protein" model in 1967.
- Gajdusek and kuru (1950s–1976). Carleton Gajdusek connected the kuru epidemic among the Fore of Papua New Guinea to transumption — ritual consumption of deceased relatives' brains — and proved transmissibility by injecting patient brain material into chimpanzees, which developed the disease after long incubation. He won the 1976 Nobel Prize, though the agent was still called a "slow virus" at the time.
- Prusiner's purification and the word "prion" (1982). Stanley Prusiner enriched the scrapie infectious fraction from hamster brain and found the infectivity co-purified with a single protease-resistant protein (PrP27-30) and could not be separated from it, while nucleic-acid-destroying treatments left infectivity intact. In his 1982 Science paper he coined "prion" from "proteinaceous infectious particle" and stated the protein-only hypothesis outright. He received the 1997 Nobel Prize in Physiology or Medicine.
- The PRNP gene is the host's own (Oesch, Weissmann, et al., 1985). Cloning the PrP gene revealed the bombshell that it is a normal host gene, not a foreign one — the very same gene encodes both healthy PrPc and disease-causing PrPsc. This cemented that prion disease is a disorder of protein conformation, not of a foreign genome.
- Knockout mice are immune (Büeler, Weissmann, et al., 1993). Mice engineered to lack the Prnp gene develop normally but cannot be infected with prions — no PrPc substrate, no conversion, no disease. This experiment is the single cleanest proof that the host's own protein is the required raw material for prion propagation.
- Recombinant prions made from scratch (Legname, Prusiner, et al., 2004). Synthetic prions generated from bacterially produced recombinant PrP, refolded into amyloid and injected into mice, caused bona fide transmissible prion disease. Producing infectivity from a defined, genome-free protein preparation closed the loop on the protein-only hypothesis first proposed decades earlier.
Frequently asked questions
How can a protein be infectious without any DNA or RNA?
A prion carries no nucleic acid genome — it is pure protein. The infectious information is stored in shape, not sequence. The normal cellular protein PrPc and the disease form PrPsc have the identical amino-acid sequence encoded by the same gene, PRNP on human chromosome 20; they differ only in how the chain folds. PrPc is roughly 42% alpha-helix and almost no beta-sheet, whereas PrPsc is around 30% alpha-helix and 43% beta-sheet. When a PrPsc molecule contacts a PrPc molecule, it acts as a template that forces the healthy protein to refold into the beta-sheet-rich conformation. That newly converted molecule then converts others, so the abnormal shape propagates exponentially. Because replication happens by conformational templating rather than by copying a genome, prions violate the classical central-dogma expectation that heritable biological information must reside in DNA or RNA. Stanley Prusiner coined the term prion — from 'proteinaceous infectious particle' — in 1982 to capture exactly this idea.
What is the difference between PrPc and PrPsc?
PrPc (cellular prion protein) is the normal, healthy form — a GPI-anchored glycoprotein of about 209 residues found on the surface of neurons and other cells. It is largely alpha-helical, monomeric, soluble in mild detergent, and fully digested by proteinase K. PrPsc (scrapie prion protein) is the misfolded, disease-causing conformer of the very same polypeptide. It is enriched in beta-sheet, aggregates into insoluble amyloid fibrils, and resists proteinase K digestion — the protease chews back only the flexible N-terminus, leaving a characteristic protease-resistant core of about 27 to 30 kilodaltons known as PrP27-30. This protease resistance is the standard diagnostic signature on a Western blot. Crucially, no chemical modification distinguishes the two forms: same sequence, same glycosylation sites, same GPI anchor. The entire difference is three-dimensional folding, which is why prion disease is fundamentally a disease of protein conformation.
What diseases do prions cause?
Prions cause transmissible spongiform encephalopathies (TSEs) — fatal, untreatable neurodegenerative diseases that riddle the brain with microscopic vacuoles, giving it a sponge-like appearance. In humans these include Creutzfeldt-Jakob disease (CJD, about 1 to 2 cases per million people per year worldwide), variant CJD (vCJD, acquired from eating BSE-contaminated beef, over 200 confirmed cases mostly in the UK), Gerstmann-Straussler-Scheinker syndrome, fatal familial insomnia, and kuru (spread by ritual cannibalism among the Fore people of Papua New Guinea). In animals they include scrapie in sheep and goats — recognized since the 18th century — bovine spongiform encephalopathy (BSE, mad cow disease) in cattle, and chronic wasting disease in deer, elk, and moose. All share the same core mechanism: templated conversion of PrPc into PrPsc, amyloid accumulation, neuronal loss, and spongiform vacuolation, typically with no immune or inflammatory response because the aberrant protein is recognized as self.
Why are prions so hard to destroy?
Prions are among the most durable pathogens known because there is no genome to damage and the beta-sheet amyloid core is extraordinarily stable. They survive standard autoclaving at 121 degrees Celsius, boiling, formaldehyde fixation, ultraviolet and ionizing radiation, and most disinfectants — treatments that easily kill bacteria and viruses by destroying nucleic acids. Effective decontamination requires harsh conditions: prolonged autoclaving at 134 degrees Celsius for at least 18 minutes, immersion in 1 to 2 molar sodium hydroxide, or soaking in undiluted (around 20,000 ppm) sodium hypochlorite bleach. This resistance is a genuine clinical hazard: contaminated neurosurgical instruments have transmitted CJD between patients, and standard hospital sterilization is not reliably sufficient, which is why suspected-prion instruments are often quarantined or destroyed rather than reused.
How did kuru reveal that prions could be transmitted?
Kuru was an epidemic of a fatal, tremor-marked neurodegenerative disease among the Fore people of the Papua New Guinea highlands in the mid-20th century, at its peak killing many mostly women and children. Physician Carleton Gajdusek showed in the 1950s and 1960s that it spread through transumption — the mortuary practice of consuming the brains and tissues of deceased relatives, in which women and children participated most. When the practice was banned in the late 1950s, kuru incidence collapsed. Gajdusek proved transmissibility by injecting brain material from kuru victims into chimpanzees, which developed the disease after long incubation, and won the 1976 Nobel Prize for it. At the time the agent was assumed to be a slow virus. Only later did Prusiner's protein-only work reframe kuru, scrapie, and CJD as prion diseases. Some Fore carry a protective PRNP polymorphism (notably a G127V variant) that arose under the selective pressure of the epidemic — a striking case of recent human evolution.
Are Alzheimer's and Parkinson's diseases caused by prions?
They are not classical infectious prion diseases, but they share the same molecular logic and are increasingly described as prion-like or prionoid. In Alzheimer's, amyloid-beta and tau, and in Parkinson's, alpha-synuclein, all misfold into beta-sheet-rich aggregates that template the conversion of normal molecules and spread through the brain along anatomically connected pathways — exactly the seeded, self-propagating mechanism prions pioneered. Experimentally, injecting aggregated tau or alpha-synuclein into animal brains seeds new pathology that spreads. The critical difference is transmissibility between individuals: there is no evidence that Alzheimer's or Parkinson's is naturally contagious the way scrapie, BSE, or vCJD are, and they are not spread by eating contaminated tissue under normal circumstances. So the prion concept has become a unifying framework for a whole class of neurodegenerative diseases, even though only the PrP-based TSEs are true infectious prions.